Amgen Inc vs. Twist Bioscience Corporation Common Stock
Amgen Inc (AMGN) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| AMGN | TWST | |
|---|---|---|
| Market Cap | $239.32 billion | $8.55 billion |
| Revenue (TTM) | $38.09 billion | $431.80 million |
| Net Income (TTM) | $8.74 billion | $-136,717,000 |
AMGN leads on 3 of 3 size & scale factors.
Valuation
| AMGN | TWST | |
|---|---|---|
| P/E Ratio | 27.29 | — |
| Price / Book | 20.48 | 19.18 |
| Price / Sales | 6.28 | 19.80 |
AMGN and TWST split the valuation factors evenly.
Profitability
| AMGN | TWST | |
|---|---|---|
| Net Margin | 22.95% | -31.66% |
| Return on Equity | 74.80% | -30.67% |
AMGN leads on 2 of 2 profitability factors.
Dividend
| AMGN | TWST | |
|---|---|---|
| Dividend Yield | 2.29% | — |
| Payout Ratio | 62.61 | — |
AMGN and TWST split the dividend factors evenly.
Risk & Sentiment
| AMGN | TWST | |
|---|---|---|
| Short Interest | 1.66% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.